A Study of LY3023414 in Japanese Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of LY3076226 in Participants With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 3 Study of Tanezumab for Chronic Low Back Pain
- Status
- COMPLETED
- Phase
- PHASE3
A Study of a New LY900014 Formulation in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Prexasertib (LY2606368) in Japanese Participants With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Different Particle Sizes of Evacetrapib in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Cephalexin Liquid in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- N/A
A Study of Abemaciclib (LY2835219) in Healthy Participants With and Without Food
- Status
- COMPLETED
- Phase
- PHASE1
Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM
- Status
- UNKNOWN
- Phase
- NA